HLS Therapeutics Investor Relations Material
Latest events
Q3 2023
HLS Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
HLS Therapeutics Inc. is a specialty pharmaceutical company that acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's strategy is to become a leading player in specialized treatments for patients suffering from neurological disorders and CV disorders.
Latest articles
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
The Story of Jensen Huang and Nvidia
When looking at NVIDIA’s Jensen Huang today, it is easy to stereotype him as your archetypical big tech CEO. He doesn’t wear suits like a Wall Street Chairman, instead opting to wear his now-iconic leather jackets and casual polo shirts.
6 Dec 2023
Neglect of Probability: A Hidden Risk in Decision Making
The concept of "probability" should take center stage in our decision-making processes.
4 Dec 2023
Ticker symbol
HLS
Country
🇨🇦 Canada